Biomarkers and targets for diagnosis, prognosis and management of prostate disease
US5882864A · kind A · utility
135Cited by
4References
64Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 31, 1996 |
| Grant date | Mar 16, 1999 |
| Priority date | — |
| Expiry date | Jul 31, 2016 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12Q2600/158
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Disclosed are diagnostic techniques for the detection of human prostate cancer. Genetic probes and methods useful in monitoring the progression and diagnosis of prostate cancer are described. The invention relates particularly to probes and methods for evaluating the presence of RNA species that are differentially expressed in prostate cancer compared to normal human prostate or benign prostatic hyperplasia.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.